ARCHIVES

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

This article is from The Cancer Letter archive.

Vol. 36 No. 33 | September 17, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Hood to form Institute for Systems Biology, To Unite Biologists, High-Tech Industry

December 17, 1999

Politics May Play Role In FDA’s Avastin Decision

May 27, 2011

NCI, Groups Disagree Over Recovery Of Funds In Cases of Scientific Fraud

October 7, 1994

Fisher Address Gap Between Clinicians Investigators, A Threat To Patient Welfare

May 28, 1993

S-1 After Surgery Improves Survival, Japanese Trial Finds

February 23, 2007

NCI Low Fat Diet Study For Stage 2 Breast Cancer Will Include Postmenopausal Tamxifen Therapy

September 20, 1985